International safety notice

Quantum Blue Anti-Infliximab, referencias LF-ADIF25 y LF-ADIF10, utilizados en combinación con el Quantum Blue Reader.

Spain / AEMPS · ESP · Oct 25, 2023

Key facts

Title Quantum Blue Anti-Infliximab, referencias LF-ADIF25 y LF-ADIF10, utilizados en combinación con el Quantum Blue Reader.
Regulator Spain / AEMPS
Country ESP
Brand Quantum Blue Anti-Infliximab, referencias LF-ADIF25 y LF-ADIF10, utilizados en combinación con el Quantum Blue Reader.
Manufacturer BÜHLMANN Laboratories AG., Suiza.
Models 1912.S1912, 08174, 91.822.52.89, LF-ADIF10, LF-ADIF25, 98873, 2023-10-09, LF-ADIF10LF-ADIF25, 1912.S, 2023-492, 29.02.2024, 28022 and 1 more
Event type Safety Notice
Date Oct 25, 2023

At a glance

  • No Recall
  • Yes Field safety notice

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About International device safety notices

Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.

Source: National medical device regulators (as listed), compiled by Orca1

Browse all International device safety notices